Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

FBRX

Forte Biosciences, Inc.

CIK 0001419041 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$36.70
↑ 16.12 (78.33%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals; Risks: Fundamentals, Options

Key stats

Market Cap
$509.60M
P/E Ratio
-6.72
EPS
-4.71
Dividend Yield
Not covered
52W Position
97%
Beta
1.16

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
12.10
P/S
Not covered
EV/Revenue
Not covered
ROE
-180.2%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

250 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 97%
$9.10$37.58

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$69.38M
Total Assets
$82.78M
Free Cash Flow
-$51.00M

Recent news